pdCSM-GPCR: predicting potent GPCR ligands with graph-based signatures

Author:

Velloso João Paulo L12345,Ascher David B23467ORCID,Pires Douglas E V2348ORCID

Affiliation:

1. Fundação Oswaldo Cruz, Instituto René Rachou, Belo Horizonte 30190-009, Brazil

2. Structural Biology and Bioinformatics, Department of Biochemistry, University of Melbourne, Melbourne 3052, Australia

3. Systems and Computational Biology, Bio21 Institute, University of Melbourne, Melbourne 3052, Australia

4. Computational Biology and Clinical Informatics, Baker Heart and Diabetes Institute, Melbourne 3004, Australia

5. Universidade Federal de Minas Gerais, Belo Horizonte 31270-901, Brazil

6. Baker Department of Cardiometabolic Health, Melbourne Medical School, University of Melbourne, Melbourne 3052, Australia

7. Department of Biochemistry, University of Cambridge, Cambridge CB2 1GA, UK

8. School of Computing and Information Systems, University of Melbourne, Melbourne 3053, Australia

Abstract

Abstract Motivation G protein-coupled receptors (GPCRs) can selectively bind to many types of ligands, ranging from light-sensitive compounds, ions, hormones, pheromones and neurotransmitters, modulating cell physiology. Considering their role in many essential cellular processes, they are one of the most targeted protein families, with over a third of all approved drugs modulating GPCR signalling. Despite this, the large diversity of receptors and their multipass transmembrane architectures make the identification and development of novel specific, and safe GPCR ligands a challenge. While computational approaches have the potential to assist GPCR drug development, they have presented limited performance and generalization capabilities. Here, we explored the use of graph-based signatures to develop pdCSM-GPCR, a method capable of rapidly and accurately screening potential GPCR ligands. Results Bioactivity data (IC50, EC50, Ki and Kd) for individual GPCRs were curated. After curation, we used the data for developing predictive models for 36 major GPCR targets, across 4 classes (A, B, C and F). Our models compose the most comprehensive computational resource for GPCR bioactivity prediction to date. Across stratified 10-fold cross-validation and blind tests, our approach achieved Pearson’s correlations of up to 0.89, significantly outperforming previous methods. Interpreting our results, we identified common important features of potent GPCRs ligands, which tend to have bicyclic rings, leading to higher levels of aromaticity. We believe pdCSM-GPCR will be an invaluable tool to assist screening efforts, enriching compound libraries and ranking candidates for further experimental validation. Availability and implementation pdCSM-GPCR predictive models and datasets used have been made available via a freely accessible and easy-to-use web server at http://biosig.unimelb.edu.au/pdcsm_gpcr/. Supplementary information Supplementary data are available at Bioinformatics Advances online.

Funder

Newton Fund RCUK-CONFAP

The Medical Research Council

Wellcome Trust

Investigator Grant from the National Health and Medical Research Council (NHMRC) of Australia

Victorian Government’s Operational Infrastructure Support Program

Coordenação de Aperfeiçoamento de Pessoal de Nível Superior—Brasil

Publisher

Oxford University Press (OUP)

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3